[1] |
吴明景. COPD患者血清炎症因子水平及其与COPD加重期的相关性[J]. 安徽医学,2016,37(7):852-854.
|
[2] |
张镜锋,谢剑斌,梁淦桐. 老年COPD患者血清hs-CRP、IL-1β、TNF-α水平的变化及临床意义[J]. 海南医学,2018,29(10):1401-1403.
|
[3] |
PAVORD I D,LETTIS S,LOCANTORE N,et al.Blood eosinophils and inhaled corticosteroid/long-acting β-2 agonist efficacy in COPD[J]. Thorax,2016,71(2):123-125.
|
[4] |
陈芳,崔敏. 维生素D与慢性阻塞性肺疾病的研究进展[J]. 医药导报,2017,36(z1):52-54.
|
[5] |
中华医学会呼吸病学分会慢性阻塞性肺疾病学组. 慢性阻塞性肺疾病诊治指南(2013年修订版)[J]. 中华结核和呼吸杂志,2013,36(4):255-264.
|
[6] |
THO N V,PARK H Y,NAKANO Y.Asthma-COPD overlap syndrome(ACOS):a diagnostic challenge[J]. Respirology,2016,21(3):414-418.
|
[7] |
KARLOH M,FLEIG MAYER A,MAURICI R,et al.The COPD assessment test:what do we know so far?A systematic review and meta-analysis about clinical outcomes prediction and classification of patients into gold stages[J]. Chest,2016,149(2):413-425.
|
[8] |
冯聪锐,何力敏,徐刚,等. 加用维生素D治疗老年COPD的效果及其对患者血清IL-33表达的影响[J]. 实用医药杂志,2017,34(7):609-612.
|
[9] |
陈淑芳,陈复辉,刘晶,等. 慢性阻塞性肺疾病的免疫治疗进展[J]. 现代医学,2016,44(10):1468-1471.
|
[10] |
KURASHIMA K,TAKAKU Y,OHTA C,et al.COPD assessment test and severity of airflow limitation in patients with asthma,COPD,and asthma-COPD overlap syndrom[J]. Int J Chron Obstruct Pulmon Dis,2016,11:479-487.
|
[11] |
廖长征,徐文莉,陈思祖. 慢性阻塞性肺疾病患者外周血T淋巴细胞凋亡检测的临床价值[J]. 检验医学,2015,30(10):971-974.
|
[12] |
徐国鹏,杨丽君,吴永华,等. 血清25(OH)D与老年慢性阻塞性肺病病人肺功能、骨骼肌功能的关系[J]. 实用老年医学,2018,3:233-236.
|
[13] |
顾峰. 慢性阻塞性肺疾病急性加重期患者血清25-羟基维生素D检测的临床意义[J]. 检验医学,2016,31(7):559-561.
|
[14] |
吴艳,赵寅滢,范晓东,等. 血嗜酸性粒细胞在慢性阻塞性肺疾病急性加重住院患者分层治疗中的临床意义[J]. 临床肺科杂志,2016,21(11):1941-1943.
|